Navigating new frontiers: Ways to find space in the future RA market
In partnership with pharmaphorum
Rheumatoid arthritis (RA) has been a major growth driver for the pharmaceutical industry over the last 15 years, led by AbbVie’s blockbuster anti-TNF inhibitor treatment Humira (adalimumab).
New appointments in our UK, Lyon and US offices
Research Partnership is delighted to announce new appointments across our offices. Boon Yap joins the Market Access team in the UK as Associate Consultant. Boon previously worked at ICON (formerly PriceSpective), where he conducted payer research and was the internal payer expert, as well as the designated country expert of China and Taiwan. Also in the UK, Scarlett Collins joins as Research Analyst and Ana Maria Barbas Coslado joins the Fieldwork team as Field Executive. In our US Philadelphia office, Megan Armano joins as Senior Research Executive. Megan has strong experience in syndicated and ad hoc quantitative research.
Research Partnership is listed in the Alantra Pharma Fast 50 annual report
Research Partnership has been ranked 42nd in the top 50 fastest-growing companies in the UK, with a compound annual growth rate of 12%.
The best performing privately-owned UK pharmaceutical businesses were revealed earlier this month with the publication of Pharma Times’ Alantra Pharma Fast 50 annual report. This year’s report is the third iteration of their annual ranking of pharmaceutical companies and comprises those businesses that have increased their revenues at the fastest rate over the past two financial years.
Infographic: Research Partnership
Did you know that we conduct over 300 projects a year in over 70 countries and covering more than 80 therapy areas?
Our latest infographic offers an overview of some key facts and figures about the company, its services and capabilities.
International Women's Day: Addressing women's health in emerging markets
Friday 8th March 2019 marks International Women's Day, a global day of action aimed at accelerating gender equality and improving women's health. Asia-Pacific Director Pei Li Teh reflects on why this is such an important issue in emerging markets.
International Women’s Day is a commemoration of the social, economic, and cultural achievements of women around the world. Furthermore, the day marks a global call to action for accelerating gender parity by improving women’s access to education and quality, affordable healthcare. Since its inception in 1909, International Women’s Day has made tremendous progress to advance gender equality. Nevertheless, figures show that globally, women’s health indicators still lag behind those of men in many aspects.